Works matching IS 09509232 AND DT 2010 AND VI 29 AND IP 34

Results: 11

EMT, cancer stem cells and drug resistance: an emerging axis of evil in the war on cancer.
Published in:
Oncogene, 2010, v. 29, n. 34, p. 4741, doi. 10.1038/onc.2010.215
By:
- Singh, A.;
- Settleman, J.
Publication type:
Article
New insights into apoptosis signaling by Apo2L/TRAIL.
Published in:
Oncogene, 2010, v. 29, n. 34, p. 4752, doi. 10.1038/onc.2010.221
By:
- Gonzalvez, F.;
- Ashkenazi, A.
Publication type:
Article
Ral activation promotes melanomagenesis.
Published in:
Oncogene, 2010, v. 29, n. 34, p. 4859, doi. 10.1038/onc.2010.224
By:
- Zipfel, P. A.;
- Brady, D. C.;
- Kashatus, D. F.;
- Ancrile, B. D.;
- Tyler, D. S.;
- Counter, C. M.
Publication type:
Article
SPROUTY-2 and E-cadherin regulate reciprocally and dictate colon cancer cell tumourigenicity.
Published in:
Oncogene, 2010, v. 29, n. 34, p. 4800, doi. 10.1038/onc.2010.225
By:
- Barbáchano, A.;
- Ordóñez-Morán, P.;
- García, J. M.;
- Sánchez, A.;
- Pereira, F.;
- Larriba, M. J.;
- Martínez, N.;
- Hernández, J.;
- Landolfi, S.;
- Bonilla, F.;
- Pálmer, H. G.;
- Rojas, J. M.;
- Muñoz, A.
Publication type:
Article
The pro-metastatic protein anterior gradient-2 predicts poor prognosis in tamoxifen-treated breast cancers.
Published in:
Oncogene, 2010, v. 29, n. 34, p. 4838, doi. 10.1038/onc.2010.228
By:
- Hrstka, R.;
- Nenutil, R.;
- Fourtouna, A.;
- Maslon, M. M.;
- Naughton, C.;
- Langdon, S.;
- Murray, E.;
- Larionov, A.;
- Petrakova, K.;
- Muller, P.;
- Dixon, M. J.;
- Hupp, T. R.;
- Vojtesek, B.
Publication type:
Article
Intermediate filament dynamics and breast cancer: Aberrant promoter methylation of the Synemin gene is associated with early tumor relapse.
Published in:
Oncogene, 2010, v. 29, n. 34, p. 4814, doi. 10.1038/onc.2010.229
By:
- Noetzel, E.;
- Rose, M.;
- Sevinc, E.;
- Hilgers, R.-D.;
- Hartmann, A.;
- Naami, A.;
- Knüchel, R.;
- Dahl, E.
Publication type:
Article
L1CAM–integrin interaction induces constitutive NF-κB activation in pancreatic adenocarcinoma cells by enhancing IL-1β expression.
Published in:
Oncogene, 2010, v. 29, n. 34, p. 4766, doi. 10.1038/onc.2010.230
By:
- Kiefel, H.;
- Bondong, S.;
- Erbe-Hoffmann, N.;
- Hazin, J.;
- Riedle, S.;
- Wolf, J.;
- Pfeifer, M.;
- Arlt, A.;
- Schäfer, H.;
- Müerköster, S. Sebens;
- Altevogt, P.
Publication type:
Article
Preneoplastic changes persist after IGF-IR downregulation and tumor regression.
Published in:
Oncogene, 2010, v. 29, n. 34, p. 4779, doi. 10.1038/onc.2010.231
By:
- Jones, R. A.;
- Petrik, J. J.;
- Moorehead, R. A.
Publication type:
Article
Topoisomerase IIα maintains genomic stability through decatenation G<sub>2</sub> checkpoint signaling.
Published in:
Oncogene, 2010, v. 29, n. 34, p. 4787, doi. 10.1038/onc.2010.232
By:
- Bower, J. J.;
- Karaca, G. F.;
- Zhou, Y.;
- Simpson, D. A.;
- Cordeiro-Stone, M.;
- Kaufmann, W. K.
Publication type:
Article
GLI3-dependent repression of DR4 mediates hedgehog antagonism of TRAIL-induced apoptosis.
Published in:
Oncogene, 2010, v. 29, n. 34, p. 4848, doi. 10.1038/onc.2010.235
By:
- Kurita, S.;
- Mott, J. L.;
- Almada, L. L.;
- Bronk, S. F.;
- Werneburg, N. W.;
- Sun, S.-Y.;
- Roberts, L. R.;
- Fernandez-Zapico, M. E.;
- Gores, G. J.
Publication type:
Article
Acquired radioresistance of human tumor cells by DNA-PK/AKT/GSK3β-mediated cyclin D1 overexpression.
Published in:
Oncogene, 2010, v. 29, n. 34, p. 4826, doi. 10.1038/onc.2010.238
By:
- Shimura, T.;
- Kakuda, S.;
- Ochiai, Y.;
- Nakagawa, H.;
- Kuwahara, Y.;
- Takai, Y.;
- Kobayashi, J.;
- Komatsu, K.;
- Fukumoto, M.
Publication type:
Article